Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950134-01-003052
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
7
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR FISCAL YEAR END DECEMBER 31, 2000 d85466e10-k405.txt 10-K405 295590
2 2ND AMENDED/RESTATED 1996 NON-EMP. DIRECTOR STOCK d85466ex10-7.txt EX-10.7 27649
3 2000 EMPLOYEE STOCK COMPENSATION PLAN d85466ex10-9.txt EX-10.9 55119
4 EMPLOYEE STOCK PURCHASE PLAN d85466ex10-10.txt EX-10.10 43221
5 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS d85466ex11-1.txt EX-11.1 3583
6 CONSENT OF ARTHUR ANDERSEN LLP d85466ex23.txt EX-23 634
7 FINANCIAL STATEMENTS OF MILLENNIUM & ILEX PARTNERS d85466ex99-1.txt EX-99.1 26242
  Complete submission text file 0000950134-01-003052.txt   454387
Mailing Address 14785 OMICRON DR SUITE 101 SAN ANTONIO TX 78245
Business Address 4545 HORIZON HILL BLVD SAN ANTONIO TX 78229 2109498200
ILEX ONCOLOGY INC (Filer) CIK: 0001001915 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-22147 | Film No.: 1590296
SIC: 8071 Services-Medical Laboratories